530057 VIVANZA

Vivanza Biosciences Share Price

 

 

Vivanza Biosciences live price: ₹2.09. It opened at ₹2 vs previous close ₹2; intraday high/low: ₹2/₹2. The 50 & 200 DMA stand at ₹1.98/₹2.23.

Vivanza Biosciences Performance

  • Today's Low
  • ₹2
  • Today's High
  • ₹2
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹3
  • Open Price₹2
  • Previous Close₹2
  • Volume9,886
  • 50 DMA₹1.98
  • 100 DMA₹2.04
  • 200 DMA₹2.23

Investment Returns

  • Over 1 Month + 5.03%
  • Over 3 Month -7.93%
  • Over 6 Month + 5.56%
  • Over 1 Year -8.33%

Smart Investing Starts Here Start SIP with Vivanza Biosciences for Steady Growth!

Invest Now

Vivanza Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -54.7
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 8
  • P/B Ratio
  • 1.7
  • Average True Range
  • 0.08
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.04
  • RSI
  • 61.28
  • MFI
  • 39.51

Vivanza Biosciences Financials

Vivanza Biosciences Technicals

EMA & SMA

Current Price
₹2.09
+ 0.1 (5.03%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹1.93
  • 50 Day
  • ₹1.98
  • 100 Day
  • ₹2.04
  • 200 Day
  • ₹2.23

Resistance and Support

2.1 Pivot Speed
  • R3 2.16
  • R2 2.14
  • R1 2.12
  • S1 2.08
  • S2 2.06
  • S3 2.04

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vivanza Biosciences has an operating revenue of Rs. 110.03 Cr. on a trailing 12-month basis. An annual revenue de-growth of -73% needs improvement, Pre-tax margin of -9% needs improvement, ROE of -17% is poor and needs improvement. The company has a debt to equity of 84%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 48 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vivanza Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-11 Quarterly Results
2025-09-01 Others Inter-alia, to consider 1. Appoint Mr. Chintan K. Patel, Practicing Company Secretary as a Scrutinizer & Secretarial Auditors of the Company. 2. Draft notice of 43rd AGM. 3. Other business matters. split from Rs. 10/- to Re. 1/-.
2025-08-13 Quarterly Results
2025-05-12 Audited Results
Date Purpose Remarks
2023-03-24 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

Vivanza Biosciences F&O

Vivanza Biosciences Shareholding Pattern

20.02%
0%
73.42%
6.56%

Vivanza Biosciences FAQs

Vivanza Biosciences share price is ₹2 As on 12 April, 2026 | 18:03

The Market Cap of Vivanza Biosciences is ₹8.4 Cr As on 12 April, 2026 | 18:03

The P/E ratio of Vivanza Biosciences is -54.7 As on 12 April, 2026 | 18:03

The PB ratio of Vivanza Biosciences is 1.7 As on 12 April, 2026 | 18:03

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23